Zacks Investment Research's Neena Mishra explains why healthcare is outperforming technology as investors look for safety from AI concerns. She highlights AI-driven advances in drug development, genomics and biotech, while comparing broader healthcare ETFs like XLV with higher-risk opportunities including IDNA, ARKG and BBH.
The Watch List
20 Nov 2026
SHARE